Saginaw company’s UTI drug approved in Canada

SAGINAW—Graminex L.L.C. announced it had received Health Canada approval for its PollenBerry Flower Pollen Extract.

The approval came under Health Canada’s Natural and Non-prescription Health Products Directorate. PollenBerry is a proprietary formulation containing Graminex G60 Flower Pollen Extract and cranberry powder.

Heallth Canada’s certification guarantees that Graminex Products meet the highest quality standards according to the guidelines of Health Canada’s Health Products and Food Branch’s Mandate. The mandated guidelines take an integrated approach to managing the risks and benefits in regards to supplements and health food, safeguarding the consumer against inferior products.

PollenBerry has been approved for use as a traditional and herbal medicine to help prevent recurrent urinary tract infections (UTIs) in women. A secondary claim was approved to help prevent recurrent urinary tract infections, which may increase in frequency and incidence after/as a result of menopause in women.

Graminex owns and manages more than 6,500 acres of farmland in Northwest Ohio to meet its customers’ needs. Graminex’s active ingredients are grown and processed for the dietary supplement, nutraceutical, pharmaceutical, food and skin care industries. Graminex markets its own line of dietary supplements, focusing on prostate care, urinary care, menopausal support, and skin care. Partnered with its distributors, retailers and manufacturers, Graminex non-solvent products are sold in more than 44 countries on six continents.

For more information, visit www.graminex.com.

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.